Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
In the crossover RCT, half of those was randomized to P&P and ePRO groups, with average age of 51.93 years and 33.78% male
Pathophysiology of cisplatin-induced acute kidney injury
GLP AI keeps those daily signals together, and the AI coach helps you read the patterns as your routine changes
Kailera IPO'd in 2025 with HRS9531 (dual GLP-1/GIP, Phase 3 China readout ~17.7% weight loss February 2026) as its lead asset and HRS-4729 (the triple agonist) as an earlier-stage follow-on
The companies are based in 12 countries, with the leading suppliers in China (16), Europe (14), and India (4)
US$ 28.38
US$ 21.88
US$ 24.73
